Epidemiology of hepatitis A and vaccination policy

Epidemiology of hepatitis A and vaccination policy

Hepatitis A (HA) is an acute infectious disease of the liver caused by the hepatitis A virus (HAV). HA disease incidence rate is closely linked to the social and economical development. The results of seroepidemiologic studies show that the prevalence of anti-HAV antibodies in population ranges from...

Full description

Bibliographic Details
Main Authors:	I. N. Indikova, V. A. Shevtsov, A. R. Volgin, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	вирусный гепатит а вакцинопрофилактика инактивированные вакцины иммуногенность hepatitis a virus vaccination inactivated vaccines immunogenicity
Online Access:	https://www.biopreparations.ru/jour/article/view/27

Similar Items

Результаты исследования по сравнительной оценке реактогенности и иммуногенности гриппозных инактивированных вакцин
Published: (2016-12-01)

Clinical-epidemiological characteristic of virus A hepatitis at military personnel during operations
by: Yu. G. Polomeyev
Published: (2004-03-01)

Vaccinoprophylaxis of Hepatitis B N.A
by: N. A. Ozeretskovsky, et al.
Published: (2015-04-01)

IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01)

Structural features of a pathology and functional condition of a thyroid gland in patients with a chronic virus hepatites В and С
by: Ye. V. Galyan, et al.
Published: (2009-04-01)

Russian virosomal vaccine Efficacy and safety evaluation
by: T. A. Grenkova, et al.
Published: (2015-12-01)

Kliniko-immunologicheskie varianty ostrykh virusnykh gepatitov i beremennost'
by: M M Shekhtman
Published: (2004-02-01)

Experimental Approaches to the Development of Inactivated Poliovirus Vaccine Based on Sabin Strains
by: A. P. Ivanov, et al.
Published: (2016-08-01)

The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe
by: O. G. Kurskaya, et al.
Published: (2015-06-01)

Epidemiological and Immunological Efficacy of Health Workers Vaccination against Hepatitis B
by: V. G. Akimkin, et al.
Published: (2017-08-01)

Criteria of clinic diagnosis and effectiveness of biological therapy in viral hepatitis A
by: N. P. Тolokonskaya, et al.
Published: (2012-08-01)

Prophylaxis of Acute Enteric Infections and Viral Hepatitis A under Emergency Situation in the Territory of the Amur Region
by: T. V. Korita, et al.
Published: (2014-03-01)

Liver injury under chronic viral hepatitis C against the background of opiomania: morphological characters
by: Ye. V. Beloborodova, et al.
Published: (2011-02-01)

Analysis of the combined effect of polymorphisms interferon genes OAS1, OAS3, PKR, IFNA17 and IFNG in susceptibility to chronic viral hepatitis C
by: V. A. Bychkov, et al.
Published: (2011-06-01)

Clinic-epidemiologic characteristic of viral hepatitis B in children in the Tomsk Region (1994—2009)
by: S. B. Korobeinikova, et al.
Published: (2011-08-01)

Current Meningococcal Vaccines: Advantages and Disadvantages and New Challenges
by: N. N. Kostyukova, et al.
Published: (2016-08-01)

Сomparative morphological characteristics of activity score and fibrosis stage in chronic viral hepatitis C
by: I. L. Purlik, et al.
Published: (2010-10-01)

СОСТОЯНИЕ МИКРОБИОТЫ ТОЛСТОЙ КИШКИ У БОЛЬНЫХ ХРОНИЧЕСКИМ ВИРУСНЫМ ГЕПАТИТОМ В
by: Алина Валерьевна Хабарова, et al.
Published: (2024-12-01)

ПРОГНОСТИЧНЕ ЗНАЧЕННЯ БІОМАРКЕРІВ ДИСБАЛАНСУ МІЖ ЕНЕРГЕТИЧНИМ І ПЛАСТИЧНИМ ПОТЕНЦІАЛАМИ, ДЛЯ ВИВЧЕННЯ МЕХАНІЗМУ РОЗВИТКУ ПЕЧІНКОВОЇ ЕНЦЕФАЛОПАТІЇ ПРИ ХРОНІЧНОМУ ВІРУСНОМУ ГЕПАТИТІ С
by: I.Yu. Bagmut, et al.
Published: (2017-12-01)

ДИНАМІКА ПАРАМЕТРІВ ВНУТРІШНЬОКЛІТИННОГО ГОМЕОСТАЗУ У ХВОРИХ НА ХРОНІЧНИЙ ВІРУСНИЙ ГЕПАТИТ С
by: S.M. Gramatyuk
Published: (2017-11-01)

Immunologic peculiarities of acute viral hepatitis B in dependence on infectious process outcomes
by: K. I. Chouikova, et al.
Published: (2006-09-01)

The Investigation of the Prospects for Using NS4A Antigen of Hepatitis C Virus for the Development of Recombinant Mosaic Vaccines with Self-Adjuvant Properties
by: V. V. Koupriyanov, et al.
Published: (2017-02-01)

Functional significance of polymorphism of ApoE and SOD2 genes in formation of chronic HCV infection
by: N. A. Semyonova, et al.
Published: (2009-06-01)

<i>Haemophilus</i><i> influenzae</i> type <i>b</i>. Incidence rate and preventive vaccination
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Study of immunobiological properties of avian adenovirus serotype 2-based vaccine against adenovirus infection
by: A. A. Perepecha, et al.
Published: (2018-04-01)

The analysis of a long-term experience of studying inactivated cell-culture vaccines for preventing tick-borne encephalitis of domestic and foreign manufacture in terms of specific activity (immunogenicity)
by: M. S. Vorobieva, et al.
Published: (2018-02-01)

Immunoprophylaxis of Infectious Diseases in Russia: Condition and Perspective of Improvement
by: N. I. Brira, et al.
Published: (2017-04-01)

ВНЕПЕЧЕНОЧНЫЕ ПРОЯВЛЕНИЯ ХРОНИЧЕСКОГО ВИРУСНОГО ГЕПАТИТА С: КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ
by: Ксения Алексеевна Вютрих, et al.
Published: (2022-11-01)

Vaccination contribute to the development of personal and herd immunity
by: N. V. Medunitsyn, et al.
Published: (2018-02-01)

Features of NK cell phenotype virus genotype-driven chronic viral hepatitis C
by: Andrei A. Savchenko, et al.
Published: (2023-10-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

Фармакоэкономический анализ применения ингибиторов протеазы вируса гепатита С
Published: (2018-06-01)

Vaccines with adjuvants. Preclinical studies
by: Zh. I. Avdeeva, et al.
Published: (2018-02-01)

Experimental study of the protective effect of tuberculosis vaccines
by: D. T. Levy, et al.
Published: (2018-02-01)

Clinical and immunological efficacy of immunoprophylaxis of influenza in children with allergic diseases
by: E. G. Bokuchava, et al.
Published: (2016-12-01)

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
by: Xiaoli Wang, et al.
Published: (2023-08-01)

Prospects of Using Domestic Hepatitis B Vaccines to Ensure Sanitary and Epidemiological Well-Being
by: I. V. Fel'dblyum
Published: (2017-08-01)

Present Epidemical Situation of Viral Hepatitides and Tuberculosis Morbidity Rates in Moscow
by: A. A. Asratyan, et al.
Published: (2015-06-01)

Historical and Modern Views on the Problem of Specific Plague Prophylaxis
by: S. A. Bugorkova, et al.
Published: (2013-09-01)